Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01787461 · ClinicalTrials.gov registry record · Phase 4
A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure
A Phase 4 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 4
- Development phase
- 194
- Enrollment target
NCT01787461 is a Phase 4 study that has completed, run by Pfizer. The registered enrollment target is 194 participants.
The verdict
NCT01787461, a Phase 4 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 194 participants
- Enrollment target
Study Summary
The study hypothesis is that Imedeen will show effects on skin health, when compared to placebo over a 6 month intervention period with respect to changes in skin appearance, skin density, moisture, and in fine lines and wrinkles.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Imedeen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 194 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01787461
The ClinicalTrials.gov registry entry for NCT01787461 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 194 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01787461 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01787461 about?
NCT01787461 is a clinical study titled "A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure". The study hypothesis is that Imedeen will show effects on skin health, when compared to placebo over a 6 month intervention period with respect to changes in skin appearance, skin density, moisture, and in fine lines and wrinkles.
What is the current status of trial NCT01787461?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 194 participants. The study started on 2013-01. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01787461?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Imedeen (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01787461?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.